Nkarta (NKTX) Cash from Operations (2019 - 2026)
Nkarta (NKTX) posted quarterly Cash from Operations of 28199000.0 for Q1 2026, up 4.77% year-over-year from 26914707.11 in Q1 2025, and down 30.27% quarter-over-quarter from 21647000.0 in Q4 2025.
Nkarta (NKTX) Cash from Operations (2019 - 2026) Analysis & Trends
Nkarta's Cash from Operations history runs 8 years deep, the most recent figure standing at 28199000.0 for Q1 2026.
- In Q1 2026, Cash from Operations rose 4.77% year-over-year to 28199000.0; the TTM figure through Mar 2026 stood at 87286000.0 (up 13.41% YoY), while the FY2025 annual figure was 88699000.0, up 11.03% from the prior year.
- Cash from Operations for Q1 2026 stood at 28199000.0, down from 21647000.0 in the prior quarter.
- The five-year high for Cash from Operations was 7331000.0 in Q4 2022, with the low at 29612000.0 in Q1 2025.
- The 5-year median for Cash from Operations is 21647000.0 (2025), against an average of 21162000.0.
- The sharpest annual moves came in 2022 and 2023: Cash from Operations surged 58.28% in 2022, then slumped 218.56% in 2023.
- Nkarta's Cash from Operations stood at 7331000.0 in 2022, then plunged by 218.56% to 23354000.0 in 2023, then declined by 5.98% to 24751000.0 in 2024, then increased by 12.54% to 21647000.0 in 2025, then sank by 30.27% to 28199000.0 in 2026.
- Business Quant data shows NKTX's Cash from Operations at 28199000.0 in Q1 2026, 21647000.0 in Q4 2025, and 18687000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | Nkarta | 201.14 Mn | 201.14 Mn | - | -24.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -24.22 Mn |
| Jun 30, 2026 | -24.22 Mn |
| Mar 31, 2026 | -28.20 Mn |
| Mar 31, 2026 | -28.20 Mn |
| Dec 31, 2025 | -21.65 Mn |
| Dec 31, 2025 | -21.65 Mn |
| Sep 30, 2025 | -18.69 Mn |
| Sep 30, 2025 | -18.69 Mn |
| Jun 30, 2025 | -18.75 Mn |
| Jun 30, 2025 | -18.75 Mn |
| Mar 31, 2025 | -29.61 Mn |
| Mar 31, 2025 | -29.61 Mn |
| Dec 31, 2024 | -24.75 Mn |
| Dec 31, 2024 | -24.75 Mn |
| Sep 30, 2024 | -24.55 Mn |
| Sep 30, 2024 | -24.55 Mn |
| Jun 30, 2024 | -21.89 Mn |
| Jun 30, 2024 | -21.89 Mn |
| Mar 31, 2024 | -28.51 Mn |
| Mar 31, 2024 | -28.51 Mn |